MedTrace Logo

Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals

NCT00178035 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2013-08-02

No results posted yet for this study

Summary

This study will determine the effectiveness of total sleep deprivation (TSD) for one night plus paroxetine versus either TSD plus placebo or paroxetine alone in inducing rapid symptom resolution of major depression in the elderly.

Conditions

Interventions

DRUG

paroxetine

BEHAVIORAL

One night of Total Sleep Deprivation

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Charles F Reynolds III, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-12-31
Completion
2003-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178035 on ClinicalTrials.gov